Economic Value of Digital Technology In Healthcare

Size: px
Start display at page:

Download "Economic Value of Digital Technology In Healthcare"

Transcription

1 Economic Value of Digital Technology In Healthcare Francis Fatoye PhD, MSc (HEcon), MBA, BSc, FHEA, MCSP Professor of Health Economics and Outcomes Adjunct Professor Great Lakes University of Kisumu, Kenya

2 Learning Outcomes To understand the importance of economics in relation digital technology in healthcare. To understand the various methods of economic evaluations used to determine outcomes (value) of healthcare interventions.

3 Health Economics Application of economic theories, models and empirical techniques to the analysis of decision-making (Moriss et al. 2007). Developed to facilitate resource allocation/utilisation in health care/practice. Every decision - large or small - that we make when managing and delivering care practice is an economic decision. Such decisions always relate to the principles of supply and demand.

4 Annual Health Spending (World Bank, 2015) Botswana Canada France Ghana Germany Nigeria South Africa United Kingdom United States

5 Life Expectancy (World Bank, 2015) Botswana Canada France Ghana Germany Nigeria South Africa United Kingdom United States

6 Scarcity Scarcity means that there are limited resources to provide all health services desired by the society (Dewer, 2010). A key concept in Health Economics.

7 Scarcity (Truog et al. 2006) Workforce Equipment Walking Aids

8 Economic Evaluation Economic evaluation is the quantification of changes in healthcare resource utilisation because of introducing an alternative course of action (Newhouse, 2010). It identifies, measures, values and compares the costs and consequences of alternatives that are solutions to the same problem (Drummond et al., 2005).

9 Economic Evaluation Methods Method Cost Effectiveness Analysis Cost Benefit Analysis Cost Utility Analysis Cost Minimisation Analysis Cost Consequence Analysis Measure Natural units Monetary value Quality Adjusted Life Year (QALY s) = (QoL x Life Expectancy) Equal or identical benefit Descriptive terms

10 Costing: Type of Costs Direct costs: Medical costs (e.g. costs of treatment, cost of staff time, diagnostic tests, equipment). Patient costs (e.g. out-of-pocket costs for over-the-counter medicines, transport to and from hospital). Indirect costs these include the costs of lost productivity through absence from work. Intangible costs include the pain and suffering that may be associated with treatment (e.g. adverse drug reactions). These are the most difficult to which to attach monetary value

11 Costing: Perspectives Healthcare Societal Patient or Carer (Out-of-pocket expenses)

12 Measuring Costs Practitioner/researcher-led Interviews Patient/carer-reported questionnaire/dairy Patient databases/registries/medical records

13 Incremental Cost Effectiveness Ratio (ICER) ICER = Cost of intervention 2 Cost of intervention 1 Benefits of intervention 2 Benefits of intervention 1 Intervention 2 = New intervention Intervention 1 = Control/usual care

14 Costs Intervention 2 = 17,500 Intervention 1 = 12,500 Benefits Intervention 2 = 0.6 QALY Intervention 1 = 0.35 QALY ICER - Example ICER = 17,500 12,500 = 5000 = 20,000/QALY

15

16

17 Hollinghurst et al. (2013) Intervention PhysioDirect involving telephone assessment, advice and face-to-face Control group (743 pts) Usual care face-to face Perspective (1506) Patient, NHS, Society Design CCA; CUA Outcome measures SF-36, global improvement score, patient satisfaction, QALYs, cost data etc Results: No difference in cost of physio, other NHS services, personal costs, time off work Cost of PT and QALY gained were higher in PhysioDirect, ICER = 2889

18 Hollinghurst et al. (2013)

19

20 Kidholme et al. (2016) Results: Both total cost and QALY gained were higher in the intervention group ICER = 518,280/QALY Intervention (64 pts) Cardiac Telephone Rehabilitation Control group (55 pts) Traditional Cardiac Rehabilitation Perspective Health Service Design CUA Outcome measures SF-36; QALY

21 Group Activity

22 The Cost Effectiveness Plane

23 COST E.g. 20,000 per QALY Alternative less effective and more costly E B Alternative more effective but more costly D A BENEFIT/EFFECTIVENESS Alternative cheaper but less effective C Alternative more effective and less costly

24 Summary and Conclusions Health economics is the application of economic principles to the analysis of healthcare decision-making. Healthcare resources are scarce and demand for these resources are unlimited due to increasing life expectancy, economic constraints, innovation, and pressure to reduce costs and justify value for money. Health economics provides information to inform and improve decision-making. It is about maximising social benefits obtained from scarce healthcare resources.

25 References Chote R. Emmerson C. Frayne C. Love S. (2004). Challenges for the 2004 spending Review. Briefing Note No. 50. London: Institute for Fiscal Studies Cylus, J., and G. F. Anderson. (2007). Multinational Comparisons of Health Systems Data, The Commonwealth Fund. [Online information; accessed 20/01/15] Fuchs V. (2005). Health care spending re examined. Annals of Internal Medicine, 143; pp Morris, S., Develin, N. and Parkin, D. (2005) Economic Analysis in Health Care. Glasgow: John Wiley & Sons Ltd. Truog, R.D., Brock, D.W., Cook, D.J., Danis, M. Luce, J.M., Rubenfeld, G.D. and Levy, M.M. (2006) Rationing in the intensive care unit. Critcal Care Medicine, 34: Olsen, J.A. (2009) Principles in health economics and policy. Oxford: Oxford University Press Organisation for Economic Co-operation and Development. (2007). Health at a Glance 2007: OECD Indicators. [Online information; accessed 27/01/15] puck.sourceoecd.org/vl= /cl=14/nw=1/rpsv/health2007/g htm. Persad, G., Wertheimer, A. and Emmanuel, E. (2009) Principles for allocation of scarce medical interventions. The Lancet, 31: Reinhart U. Hussey P. and Anderson G. (2002). Cross national comparisons of health care systems using OECD data Health Affairs. 21; pp Wonderling, D. Gruen, R. and Black, N. (2005) Introduction to Health Economics (Understanding Public Health). New York: Open University Press.

Pharmacoeconomics: from Policy to Science. Olivia Wu, PhD Health Economics and Health Technology Assessment

Pharmacoeconomics: from Policy to Science. Olivia Wu, PhD Health Economics and Health Technology Assessment Pharmacoeconomics: from Policy to Science Olivia Wu, PhD Health Economics and Health Technology Assessment Potential conflicts of interest - none 2 Pharmacoeconomics: from policy to science - Why the need

More information

Basic Economic Analysis. David Epstein, Centre for Health Economics, York

Basic Economic Analysis. David Epstein, Centre for Health Economics, York Basic Economic Analysis David Epstein, Centre for Health Economics, York Contents Introduction Resource use and costs Health Benefits Economic analysis Conclusions Introduction What is economics? Choices

More information

Health Services Research and Health Economics. Paul McCrone Institute of Psychiatry, King s College London

Health Services Research and Health Economics. Paul McCrone Institute of Psychiatry, King s College London Health Services Research and Health Economics Paul McCrone Institute of Psychiatry, King s College London Key Questions What is the rationale for considering health economics? What are the key components

More information

An Introduction to Costeffectiveness

An Introduction to Costeffectiveness Health Economics: An Introduction to Costeffectiveness Analysis Subhash Pokhrel, PhD Reader in Health Economics Director, Division of Health Sciences Why do we need economic evaluation? 2017 2 Patient

More information

NICE Guidelines for HTA Issues of Controversy

NICE Guidelines for HTA Issues of Controversy NICE Guidelines for HTA Issues of Controversy Mark Sculpher, PhD Professor of Health Economics University of York, UK LMI, Medicines Agency in Norway and the Norwegian Knowledge Centre for the Health Services:

More information

Role of Economic Epidemiology: With Special Reference to HIV/AIDS

Role of Economic Epidemiology: With Special Reference to HIV/AIDS Role of Economic Epidemiology: With Special Reference to HIV/AIDS Senelani Dorothy Hove-Musekwa NUST AIMS Bulawayo Cape Town Zimbabwe South Africa Economic Epidemiology Workshop - Uganda: 3 August 2009

More information

Economic Evaluation. Introduction to Economic Evaluation

Economic Evaluation. Introduction to Economic Evaluation Economic Evaluation Introduction to Economic Evaluation This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of

More information

ARE STROKE UNITS COST EFFECTIVE? EVIDENCE FROM A NEW ZEALAND STROKE INCIDENCE AND POPULATION-BASED STUDY

ARE STROKE UNITS COST EFFECTIVE? EVIDENCE FROM A NEW ZEALAND STROKE INCIDENCE AND POPULATION-BASED STUDY ARE STROKE UNITS COST EFFECTIVE? EVIDENCE FROM A NEW ZEALAND STROKE INCIDENCE AND POPULATION-BASED STUDY Braden Te Ao, Ph.D. Centre for Health Services Research & Policy, University of Auckland, National

More information

QALYs and the QALY problem in PC. 1. Idea of the QALY 2. QALY problem in Palliative Care

QALYs and the QALY problem in PC. 1. Idea of the QALY 2. QALY problem in Palliative Care QALYs and the QALY problem in PC 1. Idea of the QALY 2. QALY problem in Palliative Care QALYs and the QALY problem in PC 1. Idea of the QALY 2. QALY problem in Palliative Care Idea of the QALY In a single

More information

Food for thought. Department of Health Services Research 1

Food for thought. Department of Health Services Research 1 Food for thought Suppose you have been asked to undertake an economic evaluation of the costs and effects on the Fall prevention program Identify the range of different costs that you might wish to include

More information

+ Economic Analyses in Clinical

+ Economic Analyses in Clinical + Economic Analyses in Clinical Trials Nicole Mittmann (and Natasha Leighl) Committee on Economic Analysis (formerly, Working Group on Economic Analysis, NCIC CTG) Natasha.Leighl@uhn.on.ca; Nicole.Mittmann@sunnybrook.ca

More information

Introduction to Cost-Effectiveness Analysis

Introduction to Cost-Effectiveness Analysis Introduction to Cost-Effectiveness Analysis Janie M. Lee, MD, MSc RSNA Clinical Trials Methodology Workshop January 13, 2016 Why is Clinical Research Important to Radiology? Radiology currently occupies

More information

TIPI di ANALISI ECONOMICHE Patrizia Berto LASER Analytica - Milano

TIPI di ANALISI ECONOMICHE Patrizia Berto LASER Analytica - Milano TIPI di ANALISI ECONOMICHE Patrizia Berto LASER Analytica - Milano 1 DIFFERENCE BETWEEN COST-CONTAINMENT AND COST-OPTIMIZATION Prices & volumes control Co-payments Control on prescriptions Allocation of

More information

The cost-effectiveness of screening blood donors for malaria by PCR Shehata N, Kohli M, Detsky A

The cost-effectiveness of screening blood donors for malaria by PCR Shehata N, Kohli M, Detsky A The cost-effectiveness of screening blood donors for malaria by PCR Shehata N, Kohli M, Detsky A Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion

More information

Evidence based assessment of the value of innovation: pricing solutions and prospects

Evidence based assessment of the value of innovation: pricing solutions and prospects Evidence based assessment of the value of innovation: pricing solutions and prospects Karl Claxton 7/11/2017 How much can we pay for innovation? Cost Price > P* 60,000 30,000 per QALY Cost-effectiveness

More information

2/20/2012. New Technology #1. The Horizon of New Health Technologies. Introduction to Economic Evaluation

2/20/2012. New Technology #1. The Horizon of New Health Technologies. Introduction to Economic Evaluation Introduction to Economic Evaluation Sean D. Sullivan, PhD Professor and Director Pharmaceutical Outcomes Research and Policy Program University of Washington The Horizon of New Health Technologies Diagnostics:

More information

Meeting Nigeria s vaccines financing needs ( )

Meeting Nigeria s vaccines financing needs ( ) Meeting Nigeria s vaccines financing needs (2016-2025) Inter-ministerial meeting discussion document April 2016 Objectives of today s inter-ministerial meeting Share the context of immunization financing

More information

Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids Beinfeld M T, Bosch J L, Isaacson K B, Gazelle G S

Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids Beinfeld M T, Bosch J L, Isaacson K B, Gazelle G S Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids Beinfeld M T, Bosch J L, Isaacson K B, Gazelle G S Record Status This is a critical abstract of an economic evaluation

More information

Access to newly licensed medicines. Scottish Medicines Consortium

Access to newly licensed medicines. Scottish Medicines Consortium Access to newly licensed medicines Scottish Medicines Consortium Modifiers The Committee has previously been provided with information about why the SMC uses modifiers in its appraisal process and also

More information

Setting The setting was institutional and tertiary care in London, Essex and Hertfordshire in the UK.

Setting The setting was institutional and tertiary care in London, Essex and Hertfordshire in the UK. Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis Knapp M, Thorgrimsen L, Patel A, Spector A, Hallam A, Woods B, Orrell M Record Status This is a critical abstract of

More information

Townsville Broadband Diabetes Telehealth Trial EVALUATION REPORT. May 2015

Townsville Broadband Diabetes Telehealth Trial EVALUATION REPORT. May 2015 Townsville Broadband Diabetes Telehealth Trial EVALUATION REPORT May 2015 A report by the Centre for Applied Health Economics (CAHE), Griffith University www.healtheconomics.com.au EXECUTIVE SUMMARY BACKGROUND

More information

A. Introduction to Health Economics. Dr Alan Haycox Reader in Health Economics Health Economics Unit University of Liverpool Management School

A. Introduction to Health Economics. Dr Alan Haycox Reader in Health Economics Health Economics Unit University of Liverpool Management School A. Introduction to Health Economics Dr Alan Haycox Reader in Health Economics Health Economics Unit University of Liverpool Management School Introduction to Health Economics Programme The programme will

More information

Panel Value Frameworks for Cancer Therapies: Are they Useful in the Context of Canadian Health Technology Assessments and Reimbursement Decisions?

Panel Value Frameworks for Cancer Therapies: Are they Useful in the Context of Canadian Health Technology Assessments and Reimbursement Decisions? Panel Value Frameworks for Cancer Therapies: Are they Useful in the Context of Canadian Health Technology Assessments and Reimbursement Decisions? 2017 CADTH Symposium Ottawa, April, 24th, 2017 Reiner

More information

Appendix. Lifetime extrapolation of data from the randomised controlled DiGEM trial

Appendix. Lifetime extrapolation of data from the randomised controlled DiGEM trial Appendix Lifetime extrapolation of data from the randomised controlled DiGEM trial Judit Simon, Alastair Gray, Philip Clarke, Alisha Wade, Andrew Neil, Andrew Farmer on behalf of the Diabetes Glycaemic

More information

Setting The setting was an outpatients department. The economic study was carried out in the UK.

Setting The setting was an outpatients department. The economic study was carried out in the UK. Effectiveness and cost-effectiveness of three types of physiotherapy used to reduce chronic low back pain disability: a pragmatic randomized trial with economic evaluation Critchley D J, Ratcliffe J, Noonan

More information

HC4 Obtain images of the retina

HC4 Obtain images of the retina HC4 Obtain images of the retina About this workforce competence This workforce competence covers how to obtain images of the eye using fundus photography within a screening programme for diabetic retinopathy

More information

Principles of decisions making at NICE

Principles of decisions making at NICE Principles of decisions making at NICE Karl Claxton Simon Walker Stephen Palmer Mark Sculpher Centre for Health Economics University of York, UK CHE/OHE Workshop, What perspective should be used in health

More information

The Economic Consequences of Diabetes: More than just a health issue

The Economic Consequences of Diabetes: More than just a health issue The Economic Consequences of Diabetes: More than just a health issue Dr Hannah Carter ADEA-QLD Conference 21 April 2018 Overview The Cost of Illness (COI) framework Direct costs of diabetes Indirect costs

More information

Using Health Economics to Inform the Development of Medical Devices. Matthew Allsop MATCH / BITECIC

Using Health Economics to Inform the Development of Medical Devices. Matthew Allsop MATCH / BITECIC Using Health Economics to Inform the Development of Medical Devices Matthew Allsop MATCH / BITECIC Overview Background to MATCH Overview of health economics in product development Concepts relating to

More information

Economic Analyses in Clinical Trials

Economic Analyses in Clinical Trials Economic Analyses in Clinical Trials Natasha Leighl (and Nicole Mittmann) Committee on Economic Analysis, NCIC CTG Natasha.Leighl@uhn.on.ca; Nicole.Mittmann@sunnybrook.ca Financial Disclosures Research

More information

PROBLEM GAMBLING 2018

PROBLEM GAMBLING 2018 PROBLEM GAMBLING IN NEW ZEALAND Not all people who play the pokies are problem gamblers. In fact, current research 1 shows that less than two percent of adults in New Zealand are susceptible to becoming

More information

Introduction. Onco-Pharmacoeconomy Training Course. Turkey ISPOR Training Course

Introduction. Onco-Pharmacoeconomy Training Course. Turkey ISPOR Training Course Onco-Pharmacoeconomy Training Course Turkey ISPOR Training Course Introduction Dr Alan Haycox Reader in Health Economics Health Economics Unit University of Liverpool Management School Course objectives

More information

The cost of cancer treatment

The cost of cancer treatment The cost of cancer treatment Lieven Annemans Ghent University Lieven.annemans@ugent.be January 2016 What s the problem? those prices are too high the budgets will explode these drugs offer survival benefit

More information

Cost-effectiveness ratios are commonly used to

Cost-effectiveness ratios are commonly used to ... HEALTH ECONOMICS... Application of Cost-Effectiveness Analysis to Multiple Products: A Practical Guide Mohan V. Bala, PhD; and Gary A. Zarkin, PhD The appropriate interpretation of cost-effectiveness

More information

The Cost-Effectiveness of a Collaborative Care Approach to Treating Depression and PTSD in the Military

The Cost-Effectiveness of a Collaborative Care Approach to Treating Depression and PTSD in the Military The Cost-Effectiveness of a Collaborative Care Approach to Treating Depression and PTSD in the Military Tara Lavelle, PhD Assistant Professor, Tufts Medical Center Institute for Clinical Research and Health

More information

UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator

UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator QOF indicator area: Hypertension Over 80 Potential output:

More information

Type of intervention Treatment. Economic study type Cost-effectiveness analysis.

Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Costs and effectiveness of pre- and post-operative home physiotherapy for total knee replacement: randomized controlled trial Mitchell C, Walker J, Walters S, Morgan A B, Binns T, Mathers N Record Status

More information

Statistical analysis of costs The results were mainly reported as deterministic data.

Statistical analysis of costs The results were mainly reported as deterministic data. Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project Roberts T E, Robinson S, Barton P M, Bryan

More information

Increasing prevalence chronic disease. Increasing demands on over-stretched NHS resources

Increasing prevalence chronic disease. Increasing demands on over-stretched NHS resources Improving effectiveness and efficiency of a Community Diabetes Nursing service through the use of remote Telemonitoring Background Ageing population Increasing prevalence chronic disease More people living

More information

PrEP provision in healthcare settings: UK and France

PrEP provision in healthcare settings: UK and France PrEP provision in healthcare settings: UK and France Dr Michael Brady Kings College Hospital Terrence Higgins Trust London Content How to integrate PrEP provision into: Sexual health services General health

More information

Critical Appraisal Skills. Professor Dyfrig Hughes Health Economist AWMSG

Critical Appraisal Skills. Professor Dyfrig Hughes Health Economist AWMSG Critical Appraisal Skills Professor Dyfrig Hughes Health Economist AWMSG Critical appraisal of economic evaluations Quality of the underlying evidence Quality of the analysis Quality of reporting 1. Quality

More information

An Overview of Health Economics Data and Expertise in Cancer

An Overview of Health Economics Data and Expertise in Cancer An Overview of Health Economics Data and Expertise in Cancer Peter Smith, (Professor of Health Policy, Imperial College London) Mauro Laudicella (Research Fellow, Imperial College London) Source: A. Maynard

More information

Study population The patient population comprised HIV-positive pregnant women whose HIV status was known.

Study population The patient population comprised HIV-positive pregnant women whose HIV status was known. Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness Ratcliffe J, Ades A E, Gibb D, Sculpher M J, Briggs A H Record Status This is a critical

More information

Treatment of Guillain-Barre syndrome: a cost-effectiveness analysis Nagpal S, Benstead T, Shumak K, Rock G, Brown M, Anderson D R

Treatment of Guillain-Barre syndrome: a cost-effectiveness analysis Nagpal S, Benstead T, Shumak K, Rock G, Brown M, Anderson D R Treatment of Guillain-Barre syndrome: a cost-effectiveness analysis Nagpal S, Benstead T, Shumak K, Rock G, Brown M, Anderson D R Record Status This is a critical abstract of an economic evaluation that

More information

Behavioural Activation for Depression. The story so far and the rise of COBRA. David Ekers PhD, MSc, ENB 650 (CBT), RMN

Behavioural Activation for Depression. The story so far and the rise of COBRA. David Ekers PhD, MSc, ENB 650 (CBT), RMN Behavioural Activation for Depression. The story so far and the rise of COBRA David Ekers PhD, MSc, ENB 650 (CBT), RMN What is Behavioural Activation Views depression as based in interaction with environment-loss

More information

Impact of health behaviours and health interventions on demand for and cost of NHS services in the North of Scotland (including Tayside)

Impact of health behaviours and health interventions on demand for and cost of NHS services in the North of Scotland (including Tayside) Impact of health behaviours and health interventions on demand for and cost of NHS services in the North of Scotland (including Tayside) Note: This paper is based on a report originally produced by Dr

More information

Value of an economic analysis on diagnostic tests conducted for the Pneumonia NICE Clinical Guideline

Value of an economic analysis on diagnostic tests conducted for the Pneumonia NICE Clinical Guideline Value of an economic analysis on diagnostic tests conducted for the Pneumonia NICE Clinical Guideline Presenter: Elisabetta Fenu, Health Economics Lead Co-author: Chris Kiff National Clinical Guideline

More information

Summary 1. Comparative effectiveness of ataluren Study 007

Summary 1. Comparative effectiveness of ataluren Study 007 Cost-effectiveness of Ataluren (Transarna TM ) for the treatment of Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophy gene in ambulatory patients aged 5 years and older The

More information

Type of intervention Secondary prevention and treatment; Other (medication coverage policy design).

Type of intervention Secondary prevention and treatment; Other (medication coverage policy design). Cost-effectiveness of full Medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes Rosen A B, Hamel M B, Weinstein M C, Cutler D M, Fendrick A, Vijan S Record Status

More information

Module 1 What is economics and economic evaluation?

Module 1 What is economics and economic evaluation? Designing Economic Evaluation Alongside Clinical Studies Health Economics Short Course For more information and course dates, please visit our website http://mdhs-study.unimelb.edu.au/short-courses/mspghshort-courses/designing-economic-evaluation-alongsideclinical-studies/overview

More information

An exploration of the cost-effectiveness of interventions to reduce. differences in the uptake of childhood immunisations in the UK using

An exploration of the cost-effectiveness of interventions to reduce. differences in the uptake of childhood immunisations in the UK using An exploration of the cost-effectiveness of interventions to reduce differences in the uptake of childhood immunisations in the UK using threshold analysis National Collaborating Centre for Women s and

More information

Health Technology Assessment and the Demands of the Fourth Hurdle Experiences from TLV in Sweden

Health Technology Assessment and the Demands of the Fourth Hurdle Experiences from TLV in Sweden 1 Health Technology Assessment and the Demands of the Fourth Hurdle Experiences from TLV in Sweden Ulf Persson IHE, The Swedish Institute for Health Economics & Institute of Economic Research, School of

More information

Invest to Save: Jackie Baillie MSP (Chair, Cross Party Group on Muscular Dystrophy) Eileen McCallum

Invest to Save: Jackie Baillie MSP (Chair, Cross Party Group on Muscular Dystrophy) Eileen McCallum Invest to Save: Invest to Save: I am pleased to welcome this briefing, which puts forward the case for investing in preventative services for people with neuromuscular conditions in Scotland. I pay tribute

More information

Setting The setting was outpatient clinics. The economic analysis was conducted in Boston, USA.

Setting The setting was outpatient clinics. The economic analysis was conducted in Boston, USA. Relative costs and effectiveness of specialist and general internist ambulatory care for patients with 2 chronic musculoskeletal conditions Anderson J J, Ruwe M, Miller D R, Kazis L, Felson D T, Prashker

More information

Post-2015: Innovative Financing of HIV/AIDS. Travis Mitchell Economic Affairs Division

Post-2015: Innovative Financing of HIV/AIDS. Travis Mitchell Economic Affairs Division Post-2015: Innovative Financing of HIV/AIDS Travis Mitchell Economic Affairs Division High Burden (HIV/AIDS) Low Income countries will remain dependent on external funding for decades, creating major financial

More information

2014/LSIF/PD/030 Risk Assessment and Cost-Effectiveness of Blood Safety Interventions for HIV, HCV, and HBV Development of a Web-Based Application

2014/LSIF/PD/030 Risk Assessment and Cost-Effectiveness of Blood Safety Interventions for HIV, HCV, and HBV Development of a Web-Based Application 2014/LSIF/PD/030 Risk Assessment and Cost-Effectiveness of Blood Safety Interventions for HIV, HCV, and HBV Development of a Web-Based Application Submitted by: Blood Systems Research Institute (BSRI)

More information

Health Economics & Nutrition Economics

Health Economics & Nutrition Economics Health Economics & Nutrition Economics Cost & cost effectiveness nutrition therapy Karen Freijer, PhD, BSc 30 September 2017 k.freyer@maastrichtuniversity.nl Chair ISPOR Nutrition Economics SIG http://www.ispor.org/sigs/nutritionecon

More information

UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator

UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator QOF indicator area: Hypertension Under 80 Potential output:

More information

ACTIVE TAMESIDE STRATEGY, GROWTH AND DEVELOPMENT

ACTIVE TAMESIDE STRATEGY, GROWTH AND DEVELOPMENT Report to: HEALTH AND WELLBEING BOARD Date: 19 January 2017 Board Member / Reporting Officer: Subject: Report Summary: Recommendations: Links to Health and Wellbeing Strategy: Policy Implications: Financial

More information

Back to the future: should we live in a post-qaly world?

Back to the future: should we live in a post-qaly world? Back to the future: should we live in a post-qaly world? Moderator: John Spoors, Senior Analytical Lead, NHS By Ad England Rietveld john.spoors@nhs.net RJW&partners Presenters: Andrew Walker Ad Rietveld

More information

Adjunctive therapy in epilepsy: a cost-effectiveness comparison of alternative treatment options

Adjunctive therapy in epilepsy: a cost-effectiveness comparison of alternative treatment options Seizure 1995: 4:37-44 Adjunctive therapy in epilepsy: a cost-effectiveness comparison of alternative treatment options B.A. O'NEILL, M.R. TRIMBLE* & D.S. BLOOM Arthur D. Little Ltd, Berkley Square House,

More information

Economic Analysis of Interventions for Smoking Cessation Aimed at Pregnant Women

Economic Analysis of Interventions for Smoking Cessation Aimed at Pregnant Women Y O R K Health Economics C O N S O R T I U M NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Economic Analysis of Interventions for Smoking Cessation Aimed at Pregnant Women Supplementary Report

More information

Health Economic Assessment: Cost-Effectiveness Thresholds and Other Decision Criteria

Health Economic Assessment: Cost-Effectiveness Thresholds and Other Decision Criteria Int. J. Environ. Res. Public Health 2010, 7, 1835-1840; doi:10.3390/ijerph7041835 Reply OPEN ACCESS International Journal of Environmental Research and Public Health ISSN 1660-4601 www.mdpi.com/journal/ijerph

More information

Setting The setting was outpatient. The economic study was carried out in the USA.

Setting The setting was outpatient. The economic study was carried out in the USA. Economic evaluation of the fentanyl transdermal system for the treatment of chronic moderate to severe pain Neighbors D M, Bell T J, Wilson J, Dodd S L Record Status This is a critical abstract of an economic

More information

Setting The setting was primary care (general medical practice). The economic study was carried out in Germany.

Setting The setting was primary care (general medical practice). The economic study was carried out in Germany. Pragmatic randomized trial evaluating the clinical and economic effectiveness of acupuncture for chronic low back pain Witt C M, Jena S, Selim D, Brinkhaus B, Reinhold T, Wruck K, Liecker B, Linde K, Wegscheider

More information

Mpho Moyo and Mariama Deen-Swarray

Mpho Moyo and Mariama Deen-Swarray Gender and Entrepreneurship in the informal sector: An African perspective Mpho Moyo and Mariama Deen-Swarray CPRsouth 8/CPRafrica 2013 Mysore, India September 2013 1 Introduction limited literature on

More information

Study population The study population comprised HIV-infected pregnant women seeking antenatal care.

Study population The study population comprised HIV-infected pregnant women seeking antenatal care. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries Sweat M D, O'Reilly K R, Schmid G P, Denison J, de Zoysa I Record Status This is a critical abstract

More information

The health economic landscape of cancer in Europe

The health economic landscape of cancer in Europe 1 Approval number The health economic landscape of cancer in Europe Bengt Jönsson, Professor Emeritus of Health Economics Stockholm School of Economics 2 Disclaimer This presentation was developed by Professor

More information

STAR: using visual economic models to engage stakeholders to increase value in the NHS

STAR: using visual economic models to engage stakeholders to increase value in the NHS LSE Works: LSE Health and Social Care public lecture STAR: using visual economic models to engage stakeholders to increase value in the NHS Dr Mara Airoldi Departmental Lecturer in Economics and Public

More information

Realising the potential of AHPs to support those with cancer in the future

Realising the potential of AHPs to support those with cancer in the future Realising the potential of AHPs to support those with cancer in the future June Davis National cancer rehabilitation lead Macmillan Cancer Support 1 st June 2016 The shifting pattern of survival Total

More information

Repositioning AIDS: The World Bank s Approach to Improved Efficiency and Effectiveness Using HIV Program Science Principles

Repositioning AIDS: The World Bank s Approach to Improved Efficiency and Effectiveness Using HIV Program Science Principles Repositioning AIDS: The World Bank s Approach to Improved Efficiency and Effectiveness Using HIV Program Science Principles Marelize Gorgens mgorgens@worldbank.org The World Bank s Global HIV/AIDS Program

More information

Neurological services We help people after illness or injury

Neurological services We help people after illness or injury Neurological services We help people after illness or injury In this issue... WOW Awards Our Family Nurse Partnership wins an award! Life begins at 40! Healthy relationships for older adults Christmas

More information

A BRIEF GUIDE OF HEALTH ECONOMICS

A BRIEF GUIDE OF HEALTH ECONOMICS A BRIEF GUIDE OF HEALTH ECONOMICS Jaiberth Antonio Cardona Arias, MSc 1. 1 Escuela de Microbiología, Universidad de Antioquia. Recibido: 2 de agosto del 2015 Aprobado: 15 de noviembre del 2015 *Autor de

More information

7/30/2017. One World Medical Physics: Challenges and Opportunities in Cancer Care. Worldwide Demographic Shift

7/30/2017. One World Medical Physics: Challenges and Opportunities in Cancer Care. Worldwide Demographic Shift People 60 Years and Older ( in Millions) 7/30/2017 One World Medical Physics: Challenges and Opportunities in Cancer Care Jatinder R Palta PhD, FAAPM, FASTRO, FACR Virginia Commonwealth University, and

More information

Our Plans for Improving Your Health

Our Plans for Improving Your Health Our Plans for Improving Your Health Lewisham Clinical Commissioning Group Our Plans for Improving Your Health This summary sets out how Lewisham GPs are planning to use available NHS resources to make

More information

The evaluation of individual Cognitive Stimulation Therapy (icst) for dementia. Lauren Yates Research assistant & PhD student

The evaluation of individual Cognitive Stimulation Therapy (icst) for dementia. Lauren Yates Research assistant & PhD student The evaluation of individual Cognitive Stimulation Therapy (icst) for dementia Lauren Yates Research assistant & PhD student What is CST? 7 week group programme of activities Spector et al. (2003): cognitive

More information

Study population Patients with intermittent claudication or critical ischaemia due to an iliac arterial stenosis.

Study population Patients with intermittent claudication or critical ischaemia due to an iliac arterial stenosis. Iliac arterial occlusive disease: cost-effectiveness analysis of stent placement versus percutaneous transluminal angioplasty Bosch J L, Tetteroo E, Mali W P, Hunink M G Record Status This is a critical

More information

The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events Schmier J K, Rachman N J, Halpern M T

The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events Schmier J K, Rachman N J, Halpern M T The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events Schmier J K, Rachman N J, Halpern M T Record Status This is a critical abstract of an economic evaluation that

More information

Cost effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan Shimbo T, Hira K, Takemura M, Fukui T

Cost effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan Shimbo T, Hira K, Takemura M, Fukui T Cost effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan Shimbo T, Hira K, Takemura M, Fukui T Record Status This is a critical abstract of an economic evaluation

More information

Introduction. Rare Disease Research, Health Technology Assessment and Evidence for Reimbursement FORUM

Introduction. Rare Disease Research, Health Technology Assessment and Evidence for Reimbursement FORUM Rare Disease Research, Health Technology Assessment and Evidence for Reimbursement FORUM ISPOR 20 th Annual European Congress, Glasgow 6 th November, 2017 Introduction Sandra Nestler-Parr Rare Access,

More information

Value Based Health Care in the UK: NICE, VBP and the Cost-effectiveness Threshold. Eldon Spackman, MA, PhD

Value Based Health Care in the UK: NICE, VBP and the Cost-effectiveness Threshold. Eldon Spackman, MA, PhD Value Based Health Care in the UK: NICE, VBP and the Cost-effectiveness Threshold Eldon Spackman, MA, PhD Background to NICE NICE s current position on the threshold Two concepts of the threshold Why the

More information

Cost-effectiveness of multidisciplinary management of tinnitus at a specialised tinnitus centre

Cost-effectiveness of multidisciplinary management of tinnitus at a specialised tinnitus centre Cost-effectiveness of multidisciplinary management of tinnitus at a specialised tinnitus centre Maes I, Cima R, Vlaeyen J, Anteunis L, Baguley D, El Refaie A, Scheyen D, Joore M Table of contents Part

More information

Cost-utility analysis comparing free and pedicled TRAM flap for breast reconstruction Thoma A, Khuthaila D, Rockwell G, Veltri K

Cost-utility analysis comparing free and pedicled TRAM flap for breast reconstruction Thoma A, Khuthaila D, Rockwell G, Veltri K Cost-utility analysis comparing free and pedicled TRAM flap for breast reconstruction Thoma A, Khuthaila D, Rockwell G, Veltri K Record Status This is a critical abstract of an economic evaluation that

More information

2. If prasugrel is found to be both more costly and more effective than clopidogrel, to assess its costeffectiveness

2. If prasugrel is found to be both more costly and more effective than clopidogrel, to assess its costeffectiveness Cost-Effectiveness of Prasugrel vs. Clopidogrel for PCI Patients with Acute Coronary Syndromes: Results from the TRITON-TIMI TIMI 38 Trial David J. Cohen, M.D., M.Sc. Director of Cardiovascular Research

More information

NICE guidelines development Low back pain and sciatica: Management of non-specific low back pain and sciatica

NICE guidelines development Low back pain and sciatica: Management of non-specific low back pain and sciatica NICE guidelines development Low back pain and sciatica: Management of non-specific low back pain and sciatica Steven Vogel Vice Principal (Research), The British School of Osteopathy Editor-in-Chief, The

More information

LIHS Mini Master Class

LIHS Mini Master Class Alexandru Nicusor Matei 2013 CC BY-NC-ND 2.0 Measurement and valuation of health using QALYS John O Dwyer Academic Unit of Health Economics John O Dwyer University of Leeds 2015. This work is made available

More information

Combination therapy compared to monotherapy for moderate to severe Alzheimer's Disease. Summary

Combination therapy compared to monotherapy for moderate to severe Alzheimer's Disease. Summary Combination therapy compared to monotherapy for moderate to severe Alzheimer's Disease Summary Mai 17 th 2017 Background Alzheimer s disease is a serious neurocognitive disorder which is characterized

More information

NICE decisions on health care provisions in England

NICE decisions on health care provisions in England NICE decisions on health care provisions in England Matt Stevenson, Professor of Health Technology Assessment (HTA), ScHARR, University of Sheffield, UK A quick introduction I am Technical Director of

More information

THRIVE AND PROSPER. One Corporate Plan

THRIVE AND PROSPER. One Corporate Plan THRIVE AND PROSPER One Corporate Plan 2018-2025 Together the five themes in our vision will enable residents to lead healthy, long and fulfilling lives. They can access jobs and learning opportunities

More information

Expert Carers Helping Others (ECHO) A case study on carer involvement in mental health research

Expert Carers Helping Others (ECHO) A case study on carer involvement in mental health research Expert Carers Helping Others (ECHO) A case study on carer involvement in mental health research 2013 Acknowledgements This case study was written by Dr Sarah Robens, Anthropologist at Devon Partnership

More information

Health economics for device developers: a framework for assessing commercial viability

Health economics for device developers: a framework for assessing commercial viability Health economics for device developers: a framework for assessing commercial viability Amanda Chapman & Samantha Burn University of Birmingham, UK. WHO Global forum on medical devices 23 rd November 2013

More information

MPhil/PhD Application Form

MPhil/PhD Application Form Department of Economics MPhil/PhD Application Form Please enter your full correspondence details here: Applicant (Student) Details Title (Mr, Miss, Mrs) Forename Surname Telephone No. Fax No. Email Address

More information

Ethics in the context of medicine. How to develop professional values in dealing with economic issues. Isabelle Durand-Zaleski (Paris, France)

Ethics in the context of medicine. How to develop professional values in dealing with economic issues. Isabelle Durand-Zaleski (Paris, France) DISCLOSURE Dr. Isabelle Durand-Zaleski, the California Northstate University College of Medicine and Dignity Health have reported no relevant financial interests/relationships with commercial entities

More information

Managing knowledge to support appropriate use of health technologies: some insights from the UK National Health Service

Managing knowledge to support appropriate use of health technologies: some insights from the UK National Health Service Managing knowledge to support appropriate use of health technologies: some insights from the UK National Health Service Professor Jeremy Wyatt Professor of Health Informatics, University of Dundee (previously

More information

THE SECOND REVOLUTION IN HEALTH CARE

THE SECOND REVOLUTION IN HEALTH CARE THE SECOND REVOLUTION IN HEALTH CARE SUTTER HEALTH RESEARCH, DEVELOPMENT & DISSEMINATION Buzz Stewart DID YOU MISS THE FIRST REVOLUTION? NO ONE WOULD HAVE PREDICTED THE RESULT OF THE FIRST REVOLUTION HISTORY

More information

Nova Scotia Diagnostic Imaging and Pathology & Laboratory Medicine (DIPLM) Initiative. Presentation to Atlantic Directors August 23, 2012

Nova Scotia Diagnostic Imaging and Pathology & Laboratory Medicine (DIPLM) Initiative. Presentation to Atlantic Directors August 23, 2012 Nova Scotia Diagnostic Imaging and Pathology & Laboratory Medicine (DIPLM) Initiative Presentation to Atlantic Directors August 23, 2012 1 2 21 1 9 2 3 EXISTING STATE Nova Scotia has the highest incidence

More information

Health technology Pneumococcal polysaccharide vaccination was compared with no vaccination.

Health technology Pneumococcal polysaccharide vaccination was compared with no vaccination. Cost effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race Sisk J E, Whang W, Butler J C, Sneller V-P, Whitney

More information

An economic evaluation of rizatriptan in the treatment of migraine Thompson M, Gawel M, Desjardins B, Ferko N, Grima D

An economic evaluation of rizatriptan in the treatment of migraine Thompson M, Gawel M, Desjardins B, Ferko N, Grima D An economic evaluation of rizatriptan in the treatment of migraine Thompson M, Gawel M, Desjardins B, Ferko N, Grima D Record Status This is a critical abstract of an economic evaluation that meets the

More information

Bayesian methods in health economics

Bayesian methods in health economics Bayesian methods in health economics Gianluca Baio University College London Department of Statistical Science g.baio@ucl.ac.uk Seminar Series of the Master in Advanced Artificial Intelligence Madrid,

More information